North West London Clinical Trials Alliance shortlisted for national award
The North West London Clinical Trials Alliance has been shortlisted for the New Statesman’s inaugural Positive Impact Awards, in recognition of its contribution to healthcare research.
The Alliance aims to improve access to and the quality of research in the region and has been shortlisted for the Positive Impact in Healthcare Award. It's a partnership between the NIHR Clinical Research Network (CRN) North West London, the local primary care networks (PCNs) and the clinical research facilities (CRFs) at Imperial College Healthcare NHS Trust, Chelsea and Westminster Hospital NHS Foundation Trust, and London North West University Healthcare NHS Trust. Central London Community Healthcare NHS Trust and London Ambulance Service NHS Trust have also recently joined.
"I couldn't be prouder of what our alliance has achieved in such a short time."
Dr Suki Balendra, lead of the North West London Clinical Trials Alliance and Life Sciences Lead at the NIHR CRN North West London, said:
"This nomination is recognition of the power of collaboration, in this case between NHS trusts, universities, primary care services and industry. By bringing together our collective research expertise and resources, we’re much greater than the sum of our parts and can bring the latest innovations to patients more quickly.
"I couldn't be prouder of what our alliance has achieved in such a short time and am incredibly excited about the difference we can make to patients in north west London and across the world."